1. Home
  2. UG vs ANTX Comparison

UG vs ANTX Comparison

Compare UG & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • ANTX
  • Stock Information
  • Founded
  • UG 1942
  • ANTX 2017
  • Country
  • UG United States
  • ANTX United States
  • Employees
  • UG N/A
  • ANTX N/A
  • Industry
  • UG Package Goods/Cosmetics
  • ANTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UG Consumer Discretionary
  • ANTX Health Care
  • Exchange
  • UG Nasdaq
  • ANTX Nasdaq
  • Market Cap
  • UG 36.8M
  • ANTX 37.3M
  • IPO Year
  • UG N/A
  • ANTX 2022
  • Fundamental
  • Price
  • UG $8.03
  • ANTX $1.22
  • Analyst Decision
  • UG
  • ANTX Buy
  • Analyst Count
  • UG 0
  • ANTX 4
  • Target Price
  • UG N/A
  • ANTX $2.00
  • AVG Volume (30 Days)
  • UG 12.8K
  • ANTX 134.1K
  • Earning Date
  • UG 05-08-2025
  • ANTX 05-16-2025
  • Dividend Yield
  • UG 8.72%
  • ANTX N/A
  • EPS Growth
  • UG 4.82
  • ANTX N/A
  • EPS
  • UG 0.63
  • ANTX N/A
  • Revenue
  • UG $11,408,154.00
  • ANTX N/A
  • Revenue This Year
  • UG N/A
  • ANTX N/A
  • Revenue Next Year
  • UG N/A
  • ANTX N/A
  • P/E Ratio
  • UG $11.28
  • ANTX N/A
  • Revenue Growth
  • UG N/A
  • ANTX N/A
  • 52 Week Low
  • UG $7.73
  • ANTX $0.87
  • 52 Week High
  • UG $16.25
  • ANTX $3.07
  • Technical
  • Relative Strength Index (RSI)
  • UG 41.60
  • ANTX 45.46
  • Support Level
  • UG $7.85
  • ANTX $1.05
  • Resistance Level
  • UG $8.44
  • ANTX $1.29
  • Average True Range (ATR)
  • UG 0.39
  • ANTX 0.07
  • MACD
  • UG 0.03
  • ANTX -0.00
  • Stochastic Oscillator
  • UG 22.14
  • ANTX 61.82

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Share on Social Networks: